CNTX is trading 5.1% up today at $0.61 as the stock stages a modest bounce following recent sharp volatility and heavy longer-term downside pressure.

  • There are no fresh company-specific headlines, earnings, FDA decisions, or analyst calls this morning to provide a fundamental catalyst for the move.
  • The price action appears to be driven by speculative interest in the low-priced name and broader biotech risk appetite.
  • The stock remains under significant pressure, with today's move occurring within the context of a broader downtrend.